139 related articles for article (PubMed ID: 37286465)
21. Inhibition of Hepatitis B Virus (HBV) replication and antigen expression by
Qin B; Shen S; Lai J; Yang W; Feng L; Ding J
Front Cell Infect Microbiol; 2023; 13():1193775. PubMed ID: 37560319
[TBL] [Abstract][Full Text] [Related]
22. Fibrinolysis of loculated pleural effusion in malignant mesothelioma.
Balamugesh T; Christopher DJ; Rajesh T; Prince J
Singapore Med J; 2004 Dec; 45(12):594-5. PubMed ID: 15568123
[TBL] [Abstract][Full Text] [Related]
23. Effect of
Wu J; Yang R; Zheng Q; Wei L; Wang B; Yan W; Meng S; Cheng D; Huang S; Zhang Z; Zhang P
ACS Appl Mater Interfaces; 2024 Feb; 16(8):9713-9724. PubMed ID: 38373060
[TBL] [Abstract][Full Text] [Related]
24. Intrapleural Urokinase Directly Under Medical Thoracoscopy for the Diagnosis of Malignant Pleural Mesothelioma With Severe Multiloculated Pleural Effusions.
Terashita S; Kawachi H; Horikawa S; Noguchi S; Ikeue T; Sugita T
J Bronchology Interv Pulmonol; 2019 Apr; 26(2):e26-e27. PubMed ID: 30908399
[No Abstract] [Full Text] [Related]
25. Preparation, safety, pharmacokinetics, and pharmacodynamics of liposomes containing Brucea javanica oil.
Cui Y; Wu Z; Liu X; Ni R; Zhu X; Ma L; Liu J
AAPS PharmSciTech; 2010 Jun; 11(2):878-84. PubMed ID: 20490956
[TBL] [Abstract][Full Text] [Related]
26. Network meta-analysis of 8 types of traditional Chinese medicine injection combined with chemotherapy in colorectal cancer treatment.
Gao W; Zhang K
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9823-9838. PubMed ID: 37246189
[TBL] [Abstract][Full Text] [Related]
27. Precision immunotherapy; dynamics in the cellular profile of pleural effusions in malignant mesothelioma patients.
Lievense LA; Bezemer K; Cornelissen R; Kaijen-Lambers ME; Hegmans JP; Aerts JG
Lung Cancer; 2017 May; 107():36-40. PubMed ID: 27168021
[TBL] [Abstract][Full Text] [Related]
28. Establishing mesothelioma patient-derived organoid models from malignant pleural effusions.
Hocking AJ; Mortimer LA; Farrall AL; Russell PA; Klebe S
Lung Cancer; 2024 May; 191():107542. PubMed ID: 38555809
[TBL] [Abstract][Full Text] [Related]
29. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
[TBL] [Abstract][Full Text] [Related]
30. Intrapleural immunotherapy: An update on emerging treatment strategies for pleural malignancy.
Murthy V; Katzman D; Sterman DH
Clin Respir J; 2019 May; 13(5):272-279. PubMed ID: 30810270
[TBL] [Abstract][Full Text] [Related]
31. Involvement of autophagy inhibition in
Yan Z; Zhang B; Huang Y; Qiu H; Chen P; Guo GF
Oncol Lett; 2015 Mar; 9(3):1425-1431. PubMed ID: 25663926
[No Abstract] [Full Text] [Related]
32. Mesothelioma in situ with regressive malignant pleural effusion and an unexpected evolution: A case report.
Almeida GC; Santos UP; Parente YDM; Colares PFB; Mizutani RF; Bernardi FDC; Terra RM; Terra-Filho M
Am J Ind Med; 2022 Jul; 65(7):620-623. PubMed ID: 35524457
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of Nivolumab on Sarcomatoid Malignant Pleural Mesothelioma With Eosinophilia and Eosinophilic Pleural Effusion.
Yamazoe M; Ozasa H; Kim YH
J Thorac Oncol; 2019 Nov; 14(11):e251-e253. PubMed ID: 31668324
[No Abstract] [Full Text] [Related]
34. High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma. Clinical observations and pharmacokinetic analyses.
Lerza R; Esposito M; Vannozzi M; Bottino GB; Bogliolo G; Pannacciulli I
Cancer; 1994 Jan; 73(1):79-84. PubMed ID: 8275441
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic evaluation of intrapleural perfusion with hyperthermic chemotherapy using cisplatin in patients with malignant pleural effusion.
Sakaguchi H; Ishida H; Nitanda H; Yamazaki N; Kaneko K; Kobayashi K
Lung Cancer; 2017 Feb; 104():70-74. PubMed ID: 28213004
[TBL] [Abstract][Full Text] [Related]
36. Effect of injection of brucea javanica oil emulsion plus chemoradiotherapy for lung cancer: a review of clinical evidence.
Nie YL; Liu KX; Mao XY; Li YL; Li J; Zhang MM
J Evid Based Med; 2012 Nov; 5(4):216-25. PubMed ID: 23557502
[TBL] [Abstract][Full Text] [Related]
37.
Wang Y; Chen B; Xiao M; Wang X; Peng Y
Front Pharmacol; 2022; 13():935155. PubMed ID: 35959437
[No Abstract] [Full Text] [Related]
38. Cytological Assessment of Desmoplastic Malignant Pleural Mesothelioma in an Autopsy Case.
Kawamoto Y; Kure S; Katayama H; Kawahara K; Teduka K; Kunugi S; Onda M; Motoda N; Ohashi R
J Nippon Med Sch; 2023 Feb; 89(6):616-622. PubMed ID: 34840219
[TBL] [Abstract][Full Text] [Related]
39. Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions.
Szulkin A; Otvös R; Hillerdal CO; Celep A; Yousef-Fadhel E; Skribek H; Hjerpe A; Székely L; Dobra K
BMC Cancer; 2014 Sep; 14():709. PubMed ID: 25253633
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of Brucea javanica oil emulsion injection as adjuvant therapy for cancer: An overview of systematic reviews and meta-analyses.
Chen J; Chen S; Yang X; Wang S; Wu W
Phytomedicine; 2022 Jul; 102():154141. PubMed ID: 35598523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
